top of page

Green Synergy Group

Pubblico·23 membri

Experiențe cu ArchiMate 3 Practitioner – Advised Skills vs. alți


Mă gândesc la ArchiMate 3 combinat (Foundation + Practitioner) – vreau să modelez EA corect (layere business/app/tech + value streams).

Advised Skills oferă 2 zile online în engleză/germană/franceză, workshop-uri practice, traineri cu 17–20 ani exp.

Cine a făcut? Cum se compară cu self-study sau alți provideri (Good e-Learning, QA)? Ajută în practică la tool-uri gen Archi sau Sparx?

15 visualizzazioni

Am înțeles dilema — și pentru cineva care vrea să facă EA „ca la carte” cu business/app/tech layers + value streams, ArchiMate 3 Foundation + Practitioner e o alegere logică. Cursul celor de la Advised Skills pare solid: 2 zile online, facilități practice și traineri cu experiență mare sunt plusuri importante dacă vrei structură și feedback live, nu doar materiale uscate. Mulți găsesc că self-study e ok pentru Foundation, dar Practitioner și exercițiile de modelare chiar câștigă dacă le lucrezi cu trainer. În practică te ajută mult să înțelegi conceptele înainte de a le transpune în tool-uri ca Archi sau Sparx EA, dar nu e neapărat un workshop de tool-specific. Alți provideri precum Good e-Learning sau QA sunt ok pentru teorie, dar experiența live poate accelera înțelegerea. Dacă vrei mix de teorie + practică pentru EA clar, merită să iei în considerare.Link curs https://www.advisedskills.com/ro/enterprise-architecture/archimate-3-foundation-and-practitioner-level-1-and-level-2

Modificato

Examination of Market Dynamics in the China Cell Line Development Market: Driven by Biologics Boom, Government Policy Support, and the Rise of Domestic CDMOs


The China Cell Line Development Market is one of the fastest-growing and most significant in the world, directly correlated with the nation’s unprecedented boom in biologics, biosimilars, and innovative drug development. Cell line development is a cornerstone technology supporting China’s strategic objective to transition from a manufacturer of generic small-molecule drugs to a global leader in high-value biopharmaceuticals. The market is propelled by strong government policies, such as the "Made in China 2025" initiative, which prioritizes the development of the domestic life sciences sector through substantial funding and supportive regulatory reforms that accelerate drug approval. The massive domestic patient population and the rising prevalence of chronic diseases create enormous demand for both affordable biosimilars and novel biologics. Market segmentation highlights a dominant trend in outsourcing, with…

9 visualizzazioni

I can't wait to learn more about green synergy!


hello, congratulation on the project, I am very excited to learn more about green synergy.

flavia_aneea
07 ago 2023

Hello! This is indeed exciting! I am looking forward for the educational materials to launch!


Welcome to our group Green Synergy Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.

    Green Synergy Business Development for SMEs and  Entrepreneurs

    2022-1-CY01-KA220-VET-000087187

    © 2023 Digital Kompass

    bottom of page